Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Hcw Biologics Inc (HCWB)

$0.34 +0.03 (10.12%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	2.08M
Revenue (ttm)	50,000.00
Net Income (ttm)	-7.96M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-15,920.00%
Debt to Equity Ratio	2.47

Volume	289,900
Avg Vol	10,971,371
Day's Range	N/A - N/A
Shares Out	6.73M
Stochastic %K	19%
Beta	1.13
Analysts	Strong Sell
Price Target	$2.00

Company Profile

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is i...

Industry: Biotechnology

Sector: Healthcare

Phone: 954 842 2024

Fax: 954 842 2037

Website: www.hcwbiologics.com

Address:

2929 North Commerce Parkway, Miramar, United States

Pennywarehouse May. 13 at 12:41 AM

$HCWB In few days President Trump visiting China for a comprehensive Bilateral Business meetings; Which will be very beneficial for the companies doing business in Both Countries ; Since hcwb Recently opened a Chinese Chapter in Booming China pharmacutecial Market; therefore it means Mega Chinese investments and more Hcwb products Sales Thus Results in higher Hcwb shares prices !!!

0 · Reply

Pennywarehouse May. 12 at 10:57 PM

$HCWB $ 2 please ; Pre-market opening !

0 · Reply

Atlasquantlabs May. 12 at 7:56 PM

$HCWB getting a little volume WW

0 · Reply

kim46 May. 12 at 6:33 PM

$HCWB Houston I think we have liftoff

0 · Reply

Pennywarehouse May. 8 at 3:08 PM

$HCWB Reality Mega Rebound is Coming on Monday Pre-market opening at $ 2 ! Last call Loaded up

0 · Reply

Pennywarehouse May. 1 at 11:09 AM

$HCWB Pre-market opening $ 2 ; Let's Move this full throttle .

0 · Reply

EZ_Money11 Apr. 30 at 3:53 PM

$HCWB We going to get a run over $1 soon for NASDAQ compliance?!….🚀

0 · Reply

Blue_Beirut Apr. 30 at 3:07 PM

$HCWB

0 · Reply

sarap030 Apr. 30 at 2:51 PM

$HCWB

0 · Reply

Busybilly Apr. 30 at 2:19 PM

$HCWB Whatsupp

0 · Reply

HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

2026-04-27T13:34:49.000Z - 15 days ago

HCW Biologics to file IND for HCW11-018b in first half of 2027

Apr 27, 2026, 7:30 AM EDT - 16 days ago

HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results

Mar 31, 2026, 5:05 PM EDT - 6 weeks ago

HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

HCW Biologics regains compliance with continued listing rules for Nasdaq

2026-03-02T13:38:50.000Z - 2 months ago

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting

2025-10-22T13:16:22.000Z - 7 months ago

HCW Biologics participates in virtual investor ‘What This Means’ segment

Oct 16, 2025, 9:25 AM EDT - 7 months ago

HCW Biologics to Participate in the 2025 Maxim Growth Summit

Sep 30, 2025, 8:45 AM EDT - 8 months ago

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program

2025-09-18T13:25:28.000Z - 8 months ago

HCW Biologics congratulates Wugen on equity financing

Sep 18, 2025, 9:15 AM EDT - 8 months ago

HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing

Sep 16, 2025, 8:00 AM EDT - 8 months ago

HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

HCW Biologics announces results from second-gen T-cell engager programs

2025-09-09T12:05:14.000Z - 8 months ago

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

Aug 18, 2025, 2:44 PM EDT - 9 months ago

HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 27, 2025, 7:45 AM EDT - 11 months ago

HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors

HCW Biologics regains compliance with Nasdaq Capital Market requirements

2025-06-26T12:00:52.000Z - 11 months ago

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

HCW Biologics Announces 1-for-40 Reverse Stock Split

Apr 1, 2025, 4:35 PM EDT - 1 year ago

HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

Jan 15, 2025, 7:00 AM EST - 1 year ago

HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

Dec 23, 2024, 8:10 AM EST - 1 year ago

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Nov 18, 2024, 9:27 PM EST - 1 year ago

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

Nov 18, 2024, 7:00 AM EST - 1 year ago

Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Nov 1, 2023, 7:30 AM EDT - 2 years ago

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting

Sep 6, 2023, 7:30 AM EDT - 2 years ago

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Aug 11, 2023, 7:00 AM EDT - 2 years ago

HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform

Nov 8, 2022, 7:00 AM EST - 3 years ago

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting

Pennywarehouse May. 13 at 12:41 AM

0 · Reply

Pennywarehouse May. 12 at 10:57 PM

$HCWB $ 2 please ; Pre-market opening !

0 · Reply

Atlasquantlabs May. 12 at 7:56 PM

$HCWB getting a little volume WW

0 · Reply

kim46 May. 12 at 6:33 PM

$HCWB Houston I think we have liftoff

0 · Reply

Pennywarehouse May. 8 at 3:08 PM

$HCWB Reality Mega Rebound is Coming on Monday Pre-market opening at $ 2 ! Last call Loaded up

0 · Reply

Pennywarehouse May. 1 at 11:09 AM

$HCWB Pre-market opening $ 2 ; Let's Move this full throttle .

0 · Reply

EZ_Money11 Apr. 30 at 3:53 PM

$HCWB We going to get a run over $1 soon for NASDAQ compliance?!….🚀

0 · Reply

Blue_Beirut Apr. 30 at 3:07 PM

$HCWB

0 · Reply

sarap030 Apr. 30 at 2:51 PM

$HCWB

0 · Reply

Busybilly Apr. 30 at 2:19 PM

$HCWB Whatsupp

0 · Reply

El_borracho Apr. 30 at 1:50 PM

$HCWB tic -toc

0 · Reply

SuperGreenToday Apr. 30 at 12:05 AM

$HCWB

0 · Reply

Sir_Wolf_Of_Wall_Street Apr. 29 at 6:20 PM

$HCWB 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲

0 · Reply

Lyn30 Apr. 29 at 3:25 PM

$HCWB This stock has clear path to choose imo Either they have to push over 1 and maintain to get compliance or delisting/RS which may double edged sword imo My bet on $1 push

0 · Reply

Lyn30 Apr. 29 at 2:37 PM

$HCWB Last yr July I sold this stock @ $ 5.86 Let’s see how big I can make this time

1 · Reply

Sir_Wolf_Of_Wall_Street Apr. 29 at 2:01 PM

$HCWB Wake up West Coast!!! You pancake eating mutherfuckers!!! Let's fucking go!!! 🇺🇲

0 · Reply

Pennywarehouse Apr. 29 at 11:19 AM

$HCWB Bullish !!!!

0 · Reply

Sir_Wolf_Of_Wall_Street Apr. 28 at 4:53 PM

$HCWB

0 · Reply

Lyn30 Apr. 28 at 3:26 PM

$HCWB Low float cancer stock Ca stock most of the time run big

0 · Reply

Sir_Wolf_Of_Wall_Street Apr. 28 at 1:38 PM

$HCWB 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲 🇺🇲

0 · Reply

El_borracho Apr. 28 at 10:52 AM

$HCWB Eyes on this one!!

0 · Reply

InvestingSpaceman Apr. 27 at 10:07 PM

$HCWB $CREG $CISS $GOAI Add it

0 · Reply

1.0.0